Skip to content
#explainable ai Open access

Fragment-Based Explainable AI for Pathogen-Selective Antimicrobial Drug Design

Sep 2026 · ACS Infectious Diseases · 0 citations · 25 references
Computational Drug Discovery Methods

TL;DR

The developed XAI framework, together with the pathogen-specific predictive models, the pathogen-selective fragment lists, and their mapping onto the chemical structures, is able to provide a highly valuable and practical guide to the rational design of new antimicrobial agents.

Abstract

The rise and extent of antimicrobial resistance demand computational tools that go beyond simple predictions of antimicrobial activity to deliver applicable medicinal chemistry insights for an accelerated and more efficient development of novel antimicrobials. Here, we present a fragment-based explainable artificial intelligence (XAI) framework, based on Relational Graph Convolutional Network (R-GCN) models trained with over 127,000 compounds from the Community for Open Antimicrobial Drug Discovery (CO-ADD) database and ChEMBL, targeting Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and Candida albicans (fungal). External validation on 100,000 high-throughput screening compounds from the European Chemical Biology Database (ECBD) demonstrated the predictive performance of the three models and their utility in selecting compounds from a structurally divergent library, with enrichment factors up to 19-fold. Using substructure mask explanation (SME), we further decompose each prediction into fragment-based contribution scores and map them onto the chemical structures, allowing medicinal chemists to identify which scaffolds and substituents have a positive or negative effect on the activity against specific pathogens. From correctly predicted compounds, we further extracted pathogen-selective XAI fragments representing the core scaffolds responsible for activity, allowing a comparative analysis of these selective fragments between the different microbial classes and providing an evaluation tool for the antimicrobial potential of novel compound libraries. The developed XAI framework, together with the pathogen-specific predictive models, the pathogen-selective fragment lists, and their mapping onto the chemical structures, is able to provide a highly valuable and practical guide to the rational design of new antimicrobial agents.

Read PDF

Similar papers

Open access Aug 2026

Assessing the translation of AI-prioritized genome-derived peptide fragments into validated antimicrobial candidates

This study provides an experimental assessment of model-guided AMP discovery and a reproducible route from computational prediction to validated antimicrobial candidates, while revealing biases and generalizability limits of AI-based AMP inference.

S. Ojeda, P. Ávila, S. Castellanos et al. · 0 citations
Sep 2026

Explainable Machine Learning for Predicting Antibacterial Activity of Natural Products

An explainable machine-learning framework was developed to predict antibacterial activity of natural products using data from the NPASS 3.0 database and showed the highest overall contributions, while LogP was the most influential conventional molecular descriptor.

Deepthi Goteti · 0 citations
#protein folding Review Open access Sep 2026

Lab to codes: multimodel advanced AI-driven pipelines to drive antimicrobial peptide design for the post-antibiotic era

The rapid emergence of global antimicrobial resistance (AMR) has outpaced the development of new antimicrobial agents, necessitating transformative approaches such as AI-driven in-silico drug discovery. Antimicrobial peptides (AMPs) are promising alternatives due to their broad-spectrum bactericidal activity and limite...

Naveed Saleem, E. El-Omar, Naresh Kumar et al. · 0 citations
Preprint Aug 2026

PathoMIC: A Benchmark for Cross-Species Antimicrobial Peptide Activity Prediction

With activity against multidrug-resistant pathogens and mechanisms distinct from conventional antibiotics, antimicrobial peptides (AMPs) offer a promising approach to combating antibiotic-resistant infections. However, their potency varies substantially across pathogen species, making accurate prediction of the minimum...

Ye Lu, Xiao-Yan Zhao, Fucheng Feng · 0 citations
Aug 2026

PPsAMP: A Novel Computational Framework for Short Antimicrobial Peptide Identification by Fusing Fine-Tuned Semantic and Physicochemical Features via Cross-Attention.

Experimental results demonstrate that PPsAMP significantly outperforms state-of-the-art models for identifying sAMPs, and has identified 14,839 candidate sAMPs from environmental metagenomes, most of which have not been previously reported.

Sheng-Xi Liu, Xi-Zhe Gao, Jing-Yu Wang et al. · 0 citations

Related blog posts

Google DeepMind Blog Nov 18, 2026

Genie 4 is now available

We are rolling out a new Project Genie experience to eligible Google AI Ultra subscribers, opening access to our new Genie 4 world model.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.